Poolbeg Pharma PLC (POLB) — Tangible Net Worth Ratio
Poolbeg Pharma PLC (POLB) has a Tangible Net Worth Ratio of 80.5% as of December 2025. This metric is calculated by deducting intangible assets (GBX1.67 Million) from net assets (GBX8.60 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Poolbeg Pharma PLC net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Poolbeg Pharma PLC Tangible Net Worth Ratio (2021–2025)
This chart shows how Poolbeg Pharma PLC's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 80.5%, reflecting net assets of GBX8.60 Million with intangible assets of GBX1.67 Million GBX. For live market cap and overall valuation, see Poolbeg Pharma PLC stock valuation.
Annual Tangible Net Worth Ratio for Poolbeg Pharma PLC (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Poolbeg Pharma PLC from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See POLB financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (GBX) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 80.5% | GBX8.60 Million | GBX1.67 Million | GBX9.94 Million | ▼ -1.3 pp |
| 2024 | 81.8% | GBX9.27 Million | GBX1.68 Million | GBX10.25 Million | ▼ -4.8 pp |
| 2023 | 86.6% | GBX14.44 Million | GBX1.93 Million | GBX15.43 Million | ▼ -1.7 pp |
| 2022 | 88.4% | GBX18.32 Million | GBX2.13 Million | GBX19.29 Million | ▼ -4.7 pp |
| 2021 | 93.1% | GBX22.58 Million | GBX1.56 Million | GBX23.02 Million | — |